Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Neonatology|July 28, 2011
Activation of the renin-angiotensin system in hyperoxia-induced lung fibrosis in neonatal ratsJiunn-Song Jiang, Yaw-Dong Lang, Hsiu-Chu Chou, et al.JHEP Reports : Innovation in Hepatology|December 9, 2025
Comparative effectiveness of antidiabetic therapies on hepatic decompensation in patients with type 2 diabetes: A target trial emulationJonggi Choi, Ana Verma, Vy H Nguyen, et al.The American Journal of Gastroenterology|May 12, 2026
GLP-1 receptor agonist use and liver-related outcomes in MASLD and type 2 diabetes in the All of Us Research ProgramErik Almazan, Jonggi Choi, Tushar Kamath, et al.Hepatology Communications|April 13, 2026
GLP-1RA plus SGLT2i combination therapy and liver fibrosis progression in MASLD with type 2 diabetesJonggi Choi, Gabby Mitchell, Vy H Nguyen, et al.Clinical and Molecular Hepatology|November 11, 2025
Comparative Risk of Fibrosis Progression with SGLT2 vs. DPP-4 Inhibitors in MASLD and T2DM with Low-to-Intermediate FibrosisJonggi Choi, Daniel Fulop, Vy H Nguyen, et al.Liver International : Official Journal of the International Association for the Study of the Liver|November 18, 2025
GLP-1RA and Liver Fibrosis Progression in MASLD and Type 2 Diabetes: Target Trial Emulation Using Propensity Score MatchingJonggi Choi, Tushar Kamath, Vy H Nguyen, et al.Radiation Oncology (London, England)|December 28, 2012
Hypofractionated radiotherapy for primary or secondary oligometastatic lung cancer using TomotherapyHeng-Jui Chang, Hui-Ling Ko, Cheng-Yen Lee, et al.Hepatology (Baltimore, Md.)|February 2, 2026
Association between statin use and hepatic decompensation in patients with primary biliary cholangitis: A target trial emulation studyJonggi Choi, Junqing Xu, Vy H Nguyen, et al.Nature Cell Biology|September 1, 2022
Identification of two pathways mediating protein targeting from ER to lipid dropletsJiunn Song, Arda Mizrak, Chia-Wei Lee, et al.Lung Cancer (Amsterdam, Netherlands)|January 21, 2011
Upfront gefitinib/erlotinib treatment followed by concomitant radiotherapy for advanced lung cancer: a mono-institutional experienceChih-Chia Chang, Kwan-Hwa Chi, Shang-Jyh Kao, et al.Pageof 4